rs3745647
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000590627.5(GCDH):n.232T>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.037 in 1,613,942 control chromosomes in the GnomAD database, including 1,326 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.048 ( 241 hom., cov: 33)
Exomes 𝑓: 0.036 ( 1085 hom. )
Consequence
GCDH
ENST00000590627.5 non_coding_transcript_exon
ENST00000590627.5 non_coding_transcript_exon
Scores
3
Clinical Significance
Conservation
PhyloP100: -0.0910
Publications
5 publications found
Genes affected
GCDH (HGNC:4189): (glutaryl-CoA dehydrogenase) The protein encoded by this gene belongs to the acyl-CoA dehydrogenase family. It catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA and CO(2) in the degradative pathway of L-lysine, L-hydroxylysine, and L-tryptophan metabolism. It uses electron transfer flavoprotein as its electron acceptor. The enzyme exists in the mitochondrial matrix as a homotetramer of 45-kD subunits. Mutations in this gene result in the metabolic disorder glutaric aciduria type 1, which is also known as glutaric acidemia type I. Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been identified on chromosome 12. [provided by RefSeq, Mar 2013]
GCDH Gene-Disease associations (from GenCC):
- glutaryl-CoA dehydrogenase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, G2P, Myriad Women’s Health
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 19-12891570-T-C is Benign according to our data. Variant chr19-12891570-T-C is described in ClinVar as Benign. ClinVar VariationId is 255394.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0859 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GCDH | NM_000159.4 | c.127+48T>C | intron_variant | Intron 3 of 11 | ENST00000222214.10 | NP_000150.1 | ||
| GCDH | NR_102317.1 | n.283T>C | non_coding_transcript_exon_variant | Exon 3 of 11 | ||||
| GCDH | NM_013976.5 | c.127+48T>C | intron_variant | Intron 3 of 11 | NP_039663.1 | |||
| GCDH | NR_102316.1 | n.235+48T>C | intron_variant | Intron 3 of 11 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0480 AC: 7303AN: 152178Hom.: 243 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
7303
AN:
152178
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0338 AC: 8497AN: 251134 AF XY: 0.0328 show subpopulations
GnomAD2 exomes
AF:
AC:
8497
AN:
251134
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0359 AC: 52451AN: 1461646Hom.: 1085 Cov.: 35 AF XY: 0.0357 AC XY: 25925AN XY: 727104 show subpopulations
GnomAD4 exome
AF:
AC:
52451
AN:
1461646
Hom.:
Cov.:
35
AF XY:
AC XY:
25925
AN XY:
727104
show subpopulations
African (AFR)
AF:
AC:
3100
AN:
33474
American (AMR)
AF:
AC:
1179
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
674
AN:
26134
East Asian (EAS)
AF:
AC:
483
AN:
39698
South Asian (SAS)
AF:
AC:
2785
AN:
86242
European-Finnish (FIN)
AF:
AC:
655
AN:
53392
Middle Eastern (MID)
AF:
AC:
239
AN:
5618
European-Non Finnish (NFE)
AF:
AC:
41017
AN:
1111980
Other (OTH)
AF:
AC:
2319
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
3173
6345
9518
12690
15863
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1540
3080
4620
6160
7700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0480 AC: 7307AN: 152296Hom.: 241 Cov.: 33 AF XY: 0.0452 AC XY: 3370AN XY: 74480 show subpopulations
GnomAD4 genome
AF:
AC:
7307
AN:
152296
Hom.:
Cov.:
33
AF XY:
AC XY:
3370
AN XY:
74480
show subpopulations
African (AFR)
AF:
AC:
3668
AN:
41562
American (AMR)
AF:
AC:
582
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
97
AN:
3472
East Asian (EAS)
AF:
AC:
40
AN:
5180
South Asian (SAS)
AF:
AC:
138
AN:
4830
European-Finnish (FIN)
AF:
AC:
96
AN:
10630
Middle Eastern (MID)
AF:
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2589
AN:
68002
Other (OTH)
AF:
AC:
87
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
363
726
1088
1451
1814
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
76
152
228
304
380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
89
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Glutaric aciduria, type 1 Benign:1
Jun 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.